Semaglutide
FDA Approved
The peptide that reshaped obesity medicine.
SubcutaneousOral
312 studies Peptide Encyclopedia
The Complete Peptide Reference
Evidence-based peptide profiles with clear status context, mechanism snapshots, and research depth that is fast to scan.
Explorer
Search first, then compare
18 peptide profiles in the encyclopedia.
4 FDA Approved 3 Off-Label 11 Research Only
The explorer is the main workflow on this page.
18 results
Trending
View Full Profile
Tirzepatide
FDA Approved
Next-generation dual-receptor agonist rewriting weight loss benchmarks.
Subcutaneous
187 studiesTB-500
Thymosin Beta-4 Fragment
Research Only
Accelerated healing at the cellular level.
SubcutaneousIntramuscular
67 studiesBPC-157
Body Protection Compound 157
Research Only
The body's own repair signal, amplified.
SubcutaneousOral
48 studiesIpamorelin
Research Only
Selective growth hormone release — clean, targeted, with minimal cortisol bleed.
Subcutaneous
31 studiesCJC-1295
CJC-1295 (Growth Hormone Releasing Hormone Analog)
Research Only
Sustained growth hormone release without the physiological peak-and-crash.
Subcutaneous
22 studiesLiraglutide
FDA Approved
The GLP-1 pioneer that proved peptides could transform metabolic disease.
Subcutaneous
178 studiesOxytocin
Oxytocin (OT)
Off-Label
The bonding hormone — from childbirth essential to social neuroscience frontier.
IntravenousIntranasal
127 studiesThymosin Alpha-1
Thymosin Alpha-1 (Tα1)
Off-Label
The immune system's master conductor — restoring immune competence at the cellular level.
Subcutaneous
89 studiesGHRP-2
Growth Hormone Releasing Peptide-2
Research Only
Potent GH release with validated research behind the mechanism.
SubcutaneousIntranasal
56 studiesGHK-Cu
Copper Peptide GHK-Cu (Glycine-Histidine-Lysine Copper Complex)
Research Only
Nature's aging reset — the copper-bound tripeptide found in youthful blood.
TopicalSubcutaneous
53 studiesSermorelin
Sermorelin Acetate (GHRH 1-29)
Off-Label
Restore youthful growth hormone rhythms naturally through the hypothalamus.
Subcutaneous
44 studies